Earlier and More Aggressive LDL Lowering, or Better Approaches for Targeting High-Risk Individuals?
A new review by three renowned experts in cardiology suggests that efforts to treat elevated cholesterol levels are not exploiting the full potential of cholesterol-lowering strategies, and current approaches to treatment are simply doing "too little, too late. [1]" The evidence, say these experts, is strong enough to support even more aggressive use of lipid-lowering […]
Byetta Linked to Acute Pancreatitis
Six new cases of hemorrhagic or necrotizing pancreatitis have been reported in patients using exenatide injection (Byetta, Amylin Pharmaceuticals, Inc), the US Food and Drug Administration (FDA) advised healthcare professionals today.
Capillary Blood Gas Sampling for Neonatal and Pediatric Patients
Ramaz Mitaishvili, MD1. PROCEDURE: Capillary sampling for blood gas analysis
FDA Warns About Injection Site Reactions With Naltrexone
Injectable, extended-release naltrexone (Vivitrol, Cephalon), used for the treatment of alcohol dependence, has been linked to adverse injection-site reactions, some requiring surgery, according to a US Food and Drug Administration (FDA) advisory notice to healthcare professionals released yesterday.
Sleeping With a Pacifier Lowers SIDS Risk
Babies should be put to sleep on their backs and offered a pacifier, and they should not sleep overnight in the same bed with their parents, according to surprising new guidelines designed to prevent sudden infant death syndrome (SIDS).
SIDS Cases Rise During Winter
Don't cover babies with extra blankets or clothes during winter because of the risk of SIDS (sudden infant death syndrome). That advice comes from the National Institute of Child Health and Human Development (NICHD), a branch of the National Institutes of Health (NIH).
UK Agency Urges Doctors to Cut Antibiotics
British doctors should slash the number of times they prescribe antibiotics for respiratory tract infections because the drugs rarely help, the country's drug cost watchdog said on Wednesday.
Cymbalta® is now approved for fibromyalgia
Cymbalta is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) indicated in adults for Acute and maintenance treatment of major depressive disorder (MDD) Management of diabetic peripheral neuropathic pain (DPNP) Treatment of acute generalized anxiety disorder (GAD) The management of fibromyalgia, with or without depression Although the mechanism of the antidepressant action of Cymbalta in […]
World Health Organization Issues Safety Checklist for Surgical Teams
To improve surgical safety worldwide, the World Health Organization (WHO) has released a new safety checklist for surgical teams to use in operating rooms, according to a report regarding the Safe Surgery Saves Lives initiative, published online June 25 in The Lancet and also available on the WHO Web site. These WHO guidelines and checklist […]
Post-Myocardial Infarction Cardiogenic Shock: What’s New?
Cardiogenic Shock: Current Concepts and Improving OutcomesReynolds HR, Hochman JSCirculation. 2008;117:686-697 Cardiogenic Shock: Basics and Clinical ConsiderationsGowda RM, Fox JT, Khan IA Int J Cardiol. 2008;123:221-228 Historically, cardiogenic shock (CS) was nearly always fatal after myocardial infarction (MI). Mortality rates were consistently reported at approximately 80% until the 1990s, when the mortality improved but only […]
